The initial reporter received questionable elecsys anti-sars-cov-2 s results for two patients tested on a cobas 6000 e 601 module serial number (b)(4).It was requested but not provided if the initial elecsys anti-sars-cov-2 s results were reported outside the laboratory.The customer performed repeat testing with the samples prior to calibration and after calibration, and the results for both samples had increasing values.For repeat testing, the customer did recentrifuge the samples.At 15:34, patient 1's initial elecsys anti-sars-cov-2 s result was 0.400 u/ml with a data flag and non-reactive.The patient's repeat results before calibration were 17 u/ml reactive and 29 u/ml reactive.The patient's result after calibration was 38.73 u/ml reactive.At 15:34, patient 2's initial elecsys anti-sars-cov-2 s result was 0.400 u/ml with a data flag and non-reactive.The patient's repeat result before calibration was 1.99 u/ml reactive.The patient's result after calibration was 2.23 u/ml reactive.
|
Calibration, qc, pre-analytical and instrument data were submitted and analyzed.Pre-analytical or reagent handling could not be excluded due to the limited information submitted.The investigation did not identify a product problem.The cause of the event could not be determined.
|